By Jeff Montgomery ( June 8, 2017, 8:43 PM EDT) -- Biotech licensing firm Innoviva Inc. urged a Delaware vice chancellor Thursday to grant a summary judgment denying activist hedge fund Sarissa Capital's demand for two new seats on Innoviva's board, saying the fund blew a settlement chance and then tried to recover with an unsupportable lawsuit....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.